The answer is ‘no.’ For instance, consider the case where breast cancer screening is subsidized, but you are uninsured an breast cancer treatment is unaffordable. What is the value of breast cancer screening? It is probably pretty low since if you find out you have breast cancer, there is not much you can do about [...]
Read the rest of this entry »Should all individuals be screened for Hepatitis C?
The hepatitis C virus (HCV) is largely curable: “In clinical trials, antiviral therapy with pegylated interferon and ribavirin (PEG-IFNR) has resulted in a sustained viral response (SVR) (that is, cure) of HCV infection in 46% of patients infected with genotype 1 (which infects 70% and 90% of chronically infected white and African American persons in [...]
Read the rest of this entry »Regional Variation in Diagnosis Frequency
For many years, the Dartmouth Atlas has chronicled how variation in medical resource use across the country. Despite glaring differences in the cost and volume of care across the nation, regions with higher health care costs do not necessarily have better health outcomes. However, medical treatment is a two step process. First, the physician must [...]
Read the rest of this entry »The paradox of better screening
Does better screening lead to improvements in health outcomes? Conventional wisdom holds that this is always true. For instance, catching breast cancer at an early stage greatly improves survival probabilities. However, early screening can lead to a statistical anomaly where better screening appears to improve mortality rates even when treatments are entirely ineffective. Here is [...]
Read the rest of this entry »